Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07101705
What this trial is testing

An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological Malignancies

Who this might be right for
Multiple Myeloma (MM)Non-Hodgkin Lymphoma (NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Not applicableUnknownNCT03650439
What this trial is testing

Fungal Infections in Patients With Hematological Malignancies

Who this might be right for
Fungal Infection
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT03711604
What this trial is testing

Compassionate Use Study of Tenalisib (RP6530)

Who this might be right for
Hematological Malignancies
Rhizen Pharmaceuticals SA 17
Testing effectiveness (Phase 2)Looking for participantsNCT07220616
What this trial is testing

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Who this might be right for
Hematological MalignanciesB-cell Non-Hodgkin Lymphoma
Daiichi Sankyo 420
Not applicableActive Not RecruitingNCT06849921
What this trial is testing

Precise Design of Cell Therapy for Relapsed and Refractory Hematological Tumors

Who this might be right for
Precise Design of Cell Therapy for Relapsed and Refractory Hematological TumorsHematologic Disease
Ruijin Hospital 200
Not applicableLooking for participantsNCT07373626
What this trial is testing

Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic

Who this might be right for
BehaviorMotor Activity
Azienda USL Reggio Emilia - IRCCS 50
Early research (Phase 1)Study completedNCT01588015
What this trial is testing

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+123 more
City of Hope Medical Center 36
Not applicableStudy completedNCT00581958
What this trial is testing

Radiation Biodosimetry in Patients Treated With Total Body Irradiation (TBI)

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center 198
Testing effectiveness (Phase 2)Study completedNCT03903185
What this trial is testing

Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy

Who this might be right for
Hepatitis C, ChronicHematologic Malignancy
Ain Shams University 24
Not applicableLooking for participantsNCT05041140
What this trial is testing

Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary Impairment

Who this might be right for
PulmonaryPneumoniaHematopoietic System--Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT03159702
What this trial is testing

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Who this might be right for
Hematological MalignancyMultiple Myeloma
Medical College of Wisconsin 43
Not applicableStudy completedNCT05103995
What this trial is testing

Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation

Who this might be right for
Hematological MalignanciesHaploidentical Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University 510
Testing effectiveness (Phase 2)Study completedNCT01221857
What this trial is testing

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+2 more
Gamida Cell ltd 12
Not applicableStudy completedNCT05895357
What this trial is testing

The Effect of Music Therapy on Comfort, Pain and Anxiety

Who this might be right for
Bone Marrow DiseaseHematological Malignancy
Izmir Bakircay University 66
Testing effectiveness (Phase 2)WithdrawnNCT01207128
What this trial is testing

Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis

Who this might be right for
Aspergillosis
University of Arkansas
Testing effectiveness (Phase 2)Looking for participantsNCT04959903
What this trial is testing

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Who this might be right for
Hematological Malignancies
Smart Immune SAS 36
Testing effectiveness (Phase 2)Study completedNCT00061581
What this trial is testing

Experimental Bone Marrow Transplant Protocol

Who this might be right for
Acute Lymphocytic LeukemiaChronic Myeloid LeukemiaAcute Myelocytic Leukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 14
Post-approval studies (Phase 4)UnknownNCT05612607
What this trial is testing

Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies

Who this might be right for
Secondary Antibody Deficiency
Ottawa Hospital Research Institute 100
Early research (Phase 1)Looking for participantsNCT06326463
What this trial is testing

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

Who this might be right for
Hematologic MalignancyALL, ChildhoodAML, Childhood+2 more
St. Jude Children's Research Hospital 18
Testing effectiveness (Phase 2)Study completedNCT02494258
What this trial is testing

Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders

Who this might be right for
Hematologic NeoplasmNeoplasmsHematologic Malignancies
Celgene 5
Next Page